Previous studies have reported radiomics potential role to predict molecular biomarkers in neuroblastoma, including MYCN in neuroblastoma by CT-based radiomics signature [8,25], tumor-associated macrophages by contrast-enhanced CT [26]. Here, MYCN is linked to neoplasm.